Next generation therapeutics for Alzheimer's disease
Abstract To date, no truly effective therapy has been developed for Alzheimer's disease or mild cognitive impairment. In searching for new approaches that may succeed where previous ones have failed, it may be instructive to consider the successful therapeutic developments for other chronic ill...
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artikkeli |
| Kieli: | English |
| Julkaistu: |
Springer Nature
2013-05-01
|
| Sarja: | EMBO Molecular Medicine |
| Aiheet: | |
| Linkit: | https://doi.org/10.1002/emmm.201202307 |